Results 291 to 300 of about 518,037 (342)

CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention in the Million Veteran Program

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
CYP2C19 loss‐of‐function (LOF) alleles decrease the antiplatelet effect of clopidogrel following percutaneous coronary intervention (PCI) in patients presenting with acute coronary syndrome (ACS). The impact of genotype in patients undergoing PCI for stable ischemic heart disease (SIHD) in real‐world populations is less clear.
Catherine Chanfreau‐Coffinier   +20 more
wiley   +1 more source

Unlocking efficiency in real-world collaborative studies: a multi-site international study with one-shot lossless GLMM algorithm. [PDF]

open access: yesNPJ Digit Med
Tong J   +24 more
europepmc   +1 more source

Impact of First‐of‐Its‐Kind Patient‐Facing Pharmacogenetics Tool on Dosing Decisions and Treatment Outcomes

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Germline pharmacogenetics (PGx) is increasingly used to tailor medication selection/dosing. However, existing systems primarily communicate PGx results to providers, limiting direct patient engagement. To address this, we developed YourPGx Oncology, an innovative patient‐facing portal that delivers multi‐gene PGx results (CYP2D6, UGT1A1, DPYD) through ...
Youngwoo Cho   +15 more
wiley   +1 more source

Correction: Checklist for Reproducibility of Deep Learning in Medical Imaging. [PDF]

open access: yesJ Imaging Inform Med
Moassefi M   +18 more
europepmc   +1 more source

Vaccination Schedules Recommended by the Centers for Disease Control and Prevention: From Human-Readable to Machine-Processable. [PDF]

open access: yesVaccines (Basel)
Jing X   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy